Expression of junctional proteins in choroid plexus epithelial cell lines: a comparative study

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Choroid plexus (CP) epithelial cell lines are increasingly used to model the blood-cerebrospinal fluid barrier (BCSFB).
• Existing CP cell lines (Z310, TR-CSFB3, CPC-2) have not been systematically characterized for adherens junction (AJ) and tight junction (TJ) protein expression.
• Understanding junctional protein expression is crucial for validating these cell lines as BCSFB models.

Purpose of the Study:

• To systematically characterize the expression of AJ and TJ proteins in three distinct CP epithelial cell lines.
• To evaluate the suitability of these cell lines as in vitro models for the BCSFB based on their junctional protein profiles.

Main Methods:

• Reverse-transcriptase polymerase chain reaction (RT-PCR) to assess mRNA expression.
• Western blotting to determine protein levels.
• Immunocytochemistry to localize junctional proteins within the cells.

Main Results:

• Z310 and TR-CSFB3 cells expressed occludin, zonula occludens 1, E-cadherin, and beta-catenin, with Z310 showing stronger expression.
• TR-CSFB3 cells exhibited weak expression of claudins 1 and 2, and discontinuous junctional protein staining.
• CPC-2 cells showed variable occludin localization, nuclear localization of claudin 1, and mislocalized E-cadherin, despite normal beta-catenin localization.

Conclusions:

• Significant variations in AJ and TJ protein expression exist among the studied CP cell lines.
• These expression differences suggest distinct barrier properties, impacting their utility as BCSFB models.
• Further validation is needed to select appropriate CP cell lines for specific BCSFB research.